Search results for: 'pacif infectious'

This research service presents an analysis of selected infectious disease IVD in the APAC market. The study is segmented based on the following three main methods of diagnostic technologies used: microbiology testing, immunochemistry, and molecular diagnostics. It provides in-depth analysis of infectious diseases with higher occurrence in the Asia-...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

16 Jan 2025  |  Global  |  Technology Research

Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029

The emergence of novel pathogens and the reemergence of old pathogens are driving transformational growth by pushing therapeutic advancement.

Infographics

×

Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an analysis of clinical trials for 3 treatment modaliti...

This research service covers emerging diagnostic technologies that can transform infectious disease management. CRISPR-based diagnostics: CRISPR (clustered regularly interspaced short palindromic repeats) can deliver rapid, portable and accurate diagnostics tests for field applications. This reports deals with two major US-based players developing...

The current research study discusses the available countermeasures and forthcoming allergic and infectious diseases. The most common allergic diseases such as allergic rhinitis, also know as Hay fever or seasonal allergies; sinusitis; asthma and chronic obstructive pulmonary disease (COPD); atopic dermatitis (or eczema); urticaria (or hives) and mo...

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

12 Apr 2024  |  Global  |  Customer Research

The State of the Cloud Asia-Pacific

Cloud Investments Underlie Strategies for Economic Growth and Recovery

Infographics

×

In terms of technology adoption, Asia-Pacific (APAC) is a tale of two regions. Industrialized nations, including China, Japan, and South Korea, are mature in their use of cloud and other advanced technologies. In contrast, emerging economies in Southeast Asia lag in their cloud journeys, often hindered by inconsistent access to high-capacity networ...

The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...

29 Sep 2021  |  Asia Pacific  |  Market Research

Asia-Pacific Private Cellular Networks Growth Opportunities

Disruptive Technologies and Competitive Intensity Driving Future Growth Potential

Infographics

×

The private cellular network market in the Asia-Pacific provides unique growth opportunities driven by the robust ecosystem of collaboration and availability of spectrum. The coronavirus pandemic has accelerated digital transformation for industries and driven remote and virtual enablement making reliable connectivity more critical than ever. Priva...